Grandix Pharmaceuticals Overview

  • Founded
  • 1996
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $24.2M
Latest Deal Amount

Grandix Pharmaceuticals General Information


Developer of capsules and injectibles intended to deliver painkiller. The company's capsules and injectibles provides a range of anti-diabetic, anti-hypertension and painkiller in pharmaceutical and nutraceutical products for India.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Primary Office
  • Jamals Sonu Terrace, Number 42, Loganathan Nagar
  • Ist Sreet, 100 ft. Road
  • Choolaimedu, Tamil Nadu 600094
  • India
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Grandix Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 11-Jun-2007 $24.2M 00.000 000.00 Completed Generating Revenue
1. Early Stage VC 15-Mar-2006 00.000 00.000 00.000 Completed Generating Revenue
To view Grandix Pharmaceuticals’s complete valuation and funding history, request access »

Grandix Pharmaceuticals Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Agnus Capital Venture Capital Minority 000 0000 000000 0
Xenox Venture Capital Minority 000 0000 000000 0
To view Grandix Pharmaceuticals’s complete investors history, request access »